Beilinson Hospital in central Israel has received a $34 million donation to fund cancer research, the largest of its kind in the country’s history.
Philanthropists Dr. Susan and Dr. Henry Samueli donated $25 million to establish the Samueli Integrative Cancer Pioneering Institute. Israel’s largest healthcare provider Clalit provided an additional $9 million.
The new institute will comprise experts in behavioral sciences, cancer scientists, data scientists, and artificial intelligence experts. It will also include the clinical team from the Davidoff Center, the first cancer hospital in Israel.
Both Davidoff and Beilinson are part of Rabin Medical Center, which is run by Clalit.
The institute is already at the construction stage and is recruiting specialized staff.
“The institute is keen to form partnerships and collaborations with the global cancer community, including academia, health organizations, industry and foundations – to transform cancer care and create a new future for cancer patients,” said Beilinson Hospital CEO Dr. Eytan Wirtheim.
Prof. Gal Markel, the head of the Davidoff Center and chairman of the Samueli Integrative Cancer Pioneering Institute, said: “We aim to merge the axes surrounding the patients, their families and environment with the axes of the disease, contrary to the common approach that focuses on the disease only.
“This will lead to breakthroughs from the molecular to digital level, with the goal of curing and extending the lives of cancer patients, while improving their quality of life.”
Founded in 1936, Beilinson Hospital treats more than 500,000 patients every year, has a staff of over 4,500 medical and support professionals and performs more than 70 percent of all organ transplants in Israel.
Facebook comments